132 related articles for article (PubMed ID: 25915158)
1. Small-molecule induction of phospho-eIF4E sumoylation and degradation via targeting its phosphorylated serine 209 residue.
Gu Y; Zhou H; Gan Y; Zhang J; Chen J; Gan X; Li H; Zheng W; Meng Z; Ma X; Wang X; Xu X; Xu G; Lu X; Liang Y; Zhang X; Lu X; Huang W; Xu R
Oncotarget; 2015 Jun; 6(17):15111-21. PubMed ID: 25915158
[TBL] [Abstract][Full Text] [Related]
2. Targeting of phospho-eIF4E by homoharringtonine eradicates a distinct subset of human acute myeloid leukemia.
Zhou H; Xu RZ; Gu Y; Shi PF; Qian S
Leuk Lymphoma; 2020 May; 61(5):1084-1096. PubMed ID: 29334312
[TBL] [Abstract][Full Text] [Related]
3. Sumoylation of eIF4E activates mRNA translation.
Xu X; Vatsyayan J; Gao C; Bakkenist CJ; Hu J
EMBO Rep; 2010 Apr; 11(4):299-304. PubMed ID: 20224576
[TBL] [Abstract][Full Text] [Related]
4. SENP3 regulates the global protein turnover and the Sp1 level via antagonizing SUMO2/3-targeted ubiquitination and degradation.
Wang M; Sang J; Ren Y; Liu K; Liu X; Zhang J; Wang H; Wang J; Orian A; Yang J; Yi J
Protein Cell; 2016 Jan; 7(1):63-77. PubMed ID: 26511642
[TBL] [Abstract][Full Text] [Related]
5. Homoharringtonine affects the JAK2-STAT5 signal pathway through alteration of protein tyrosine kinase phosphorylation in acute myeloid leukemia cells.
Tong H; Ren Y; Zhang F; Jin J
Eur J Haematol; 2008 Oct; 81(4):259-66. PubMed ID: 18616510
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic inhibition of MAP kinase interacting kinase blocks eukaryotic initiation factor 4E phosphorylation and suppresses outgrowth of experimental lung metastases.
Konicek BW; Stephens JR; McNulty AM; Robichaud N; Peery RB; Dumstorf CA; Dowless MS; Iversen PW; Parsons S; Ellis KE; McCann DJ; Pelletier J; Furic L; Yingling JM; Stancato LF; Sonenberg N; Graff JR
Cancer Res; 2011 Mar; 71(5):1849-57. PubMed ID: 21233335
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of eIF4E Confers Resistance to Cellular Stress and DNA-Damaging Agents through an Interaction with 4E-T: A Rationale for Novel Therapeutic Approaches.
Martínez A; Sesé M; Losa JH; Robichaud N; Sonenberg N; Aasen T; Ramón Y Cajal S
PLoS One; 2015; 10(4):e0123352. PubMed ID: 25923732
[TBL] [Abstract][Full Text] [Related]
8. Homoharringtonine binds to and increases myosin-9 in myeloid leukaemia.
Zhang T; Shen S; Zhu Z; Lu S; Yin X; Zheng J; Jin J
Br J Pharmacol; 2016 Jan; 173(1):212-21. PubMed ID: 26448459
[TBL] [Abstract][Full Text] [Related]
9. Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development.
Ueda T; Watanabe-Fukunaga R; Fukuyama H; Nagata S; Fukunaga R
Mol Cell Biol; 2004 Aug; 24(15):6539-49. PubMed ID: 15254222
[TBL] [Abstract][Full Text] [Related]
10. Homoharringtonine targets Smad3 and TGF-β pathway to inhibit the proliferation of acute myeloid leukemia cells.
Chen J; Mu Q; Li X; Yin X; Yu M; Jin J; Li C; Zhou Y; Zhou J; Suo S; Lu D; Jin J
Oncotarget; 2017 Jun; 8(25):40318-40326. PubMed ID: 28454099
[TBL] [Abstract][Full Text] [Related]
11. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway.
Nathan CO; Amirghahari N; Abreo F; Rong X; Caldito G; Jones ML; Zhou H; Smith M; Kimberly D; Glass J
Clin Cancer Res; 2004 Sep; 10(17):5820-7. PubMed ID: 15355912
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of mammalian target of rapamycin induces phosphatidylinositol 3-kinase-dependent and Mnk-mediated eukaryotic translation initiation factor 4E phosphorylation.
Wang X; Yue P; Chan CB; Ye K; Ueda T; Watanabe-Fukunaga R; Fukunaga R; Fu H; Khuri FR; Sun SY
Mol Cell Biol; 2007 Nov; 27(21):7405-13. PubMed ID: 17724079
[TBL] [Abstract][Full Text] [Related]
13. The effect of p-4E-BP1 and p-eIF4E on cell proliferation in a breast cancer model.
Pons B; Peg V; Vázquez-Sánchez MA; López-Vicente L; Argelaguet E; Coch L; Martínez A; Hernández-Losa J; Armengol G; Ramon Y Cajal S
Int J Oncol; 2011 Nov; 39(5):1337-45. PubMed ID: 21750861
[TBL] [Abstract][Full Text] [Related]
14. Activation of p53 stimulates proteasome-dependent truncation of eIF4E-binding protein 1 (4E-BP1).
Constantinou C; Elia A; Clemens MJ
Biol Cell; 2008 May; 100(5):279-89. PubMed ID: 18021075
[TBL] [Abstract][Full Text] [Related]
15. Honokiol induces cell cycle arrest and apoptosis via inhibiting class I histone deacetylases in acute myeloid leukemia.
Li HY; Ye HG; Chen CQ; Yin LH; Wu JB; He LC; Gao SM
J Cell Biochem; 2015 Feb; 116(2):287-98. PubMed ID: 25187418
[TBL] [Abstract][Full Text] [Related]
16. Eukaryotic translation initiation factor 4E as a novel therapeutic target in hematological malignancies and beyond.
Pettersson F; Del Rincon SV; Miller WH
Expert Opin Ther Targets; 2014 Sep; 18(9):1035-48. PubMed ID: 25004955
[TBL] [Abstract][Full Text] [Related]
17. SUMOylation Protects FASN Against Proteasomal Degradation in Breast Cancer Cells Treated with Grape Leaf Extract.
Floris A; Mazarei M; Yang X; Robinson AE; Zhou J; Barberis A; D'hallewin G; Azara E; Spissu Y; Iglesias-Ara A; Orrù S; Tomasi ML
Biomolecules; 2020 Mar; 10(4):. PubMed ID: 32244364
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic drug rifabutin is effective against lung cancer cells by targeting the eIF4E-β-catenin axis.
Li J; Huang Y; Gao Y; Wu H; Dong W; Liu L
Biochem Biophys Res Commun; 2016 Apr; 472(2):299-305. PubMed ID: 26944016
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of ovarian cancer growth by a tumor-targeting peptide that binds eukaryotic translation initiation factor 4E.
Ko SY; Guo H; Barengo N; Naora H
Clin Cancer Res; 2009 Jul; 15(13):4336-47. PubMed ID: 19458052
[TBL] [Abstract][Full Text] [Related]
20. PIAS1-mediated sumoylation promotes STUbL-dependent proteasomal degradation of the human telomeric protein TRF2.
Her J; Jeong YY; Chung IK
FEBS Lett; 2015 Oct; 589(21):3277-86. PubMed ID: 26450775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
